ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Effectiveness of platelet-rich plasma plus microfracture compared with microfracture alone in the treatment of knee cartilage lesions: a systematic review and meta-analysis of comparative studies.

膝軟骨病変の治療における血小板豊富血漿とマイクロフラクチャー併用の単独マイクロフラクチャーに対する有効性:比較研究の系統的レビューとメタ分析 (機械翻訳の邦題)

International journal of surgery (London, England)2026Mahamat Abdramane A, Abdirahman A, Opoku M, et al.
研究デザインその他の原著論文
対象未確定

記録の確認項目

研究デザイン
その他の原著論文
対象
未確定
出版年
2026
出典
doi.org
抄録の表示
表示あり
出版状態
有効な記録
状態確認日
2026/08/17
収集日
2026/08/04
鮮度
確認期限内
確認段階
自動処理
記録状態
公開

日本語要約(機械生成)

本研究は、膝軟骨病変に対する血小板豊富血漿(PRP)とマイクロフラクチャー(MF)の併用が、MF単独と比較して短期・中期の臨床成績を改善するかを評価するため、メタ分析を行った。PubMed等から2025年7月までの関連文献を検索し、11件の研究(RCT 6件、コホート研究5件、計664例)を解析した。その結果、PRP+MF群はMF群と比較して、VASスコア(3、12、24ヵ月)、IKDCスコア(24ヵ月)、Lysholmスコア(3、6、12、24ヵ月)、Tegnerスコア(3ヵ月)で有意な改善を示したが、WOMACスコアでは有意差はなかった。サブグループ解析では、RCTでLysholm(3、12ヵ月)とIKDC(24ヵ月)が、コホート研究でVAS(3、6、12ヵ月)、IKDC(6、24ヵ月)、Lysholm(3、6ヵ月)が有意に改善した。結論として、PRP+MFはMF単独より機能改善と疼痛コントロールに有効であるが、長期成績と安全性の確認にはさらなる高品質な研究が必要である。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

Background: Platelet-rich plasma (PRP) combined with microfracture (MF) has shown promising potential in the treatment of knee cartilage lesions. Therefore, the purpose of this study was to perform a meta-analysis to critically evaluate and compare the efficacy of using PRP + MF versus MF alone for the treatment of knee cartilage lesions in terms of short- and medium-term clinical outcomes.Method: We systematically searched the PubMed, Cochrane Library, Embase, Google Scholar, and Web of Science databases for all relevant articles published from inception to July 2025. Clinical outcomes included Visual Analog Scale (VAS), International Knee Documentation Committee (IKDC), Tegner Score, Lysholm Score, and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). An effect size with a P -value less than 0.05 was considered statistically significant. Statistical analysis was performed using the meta package in R (version 4.3.3).Results: A total of 11 studies, comprising 6 randomized controlled trials (RCTs) and 5 cohort studies, were included, totaling 664 patients. The main finding of this study is that the PRP + MF group demonstrated significantly improved VAS scores at the 3-, 12-, and 24-month follow-up; IKDC scores at the 24-month follow-up; Lysholm scores at the 3-, 6-, 12-, and 24-month follow-up; and Tegner scores at the 3-month follow-up compared to the MF group. However, there were no statistically significant differences between the two groups in the WOMAC score . Subgroup analyses showed superior Lysholm scores at 3 and 12 months and an IKDC score at 24 months in RCTs for the PRP + MF group compared to MF alone, while no significant differences were observed in VAS, Tegner, and WOMAC scores. In cohort studies, the PRP + MF group was associated with improved VAS at 3, 6, and 12 months; IKDC at 6 and 24 months, and Lysholm scores at 3 and 6 months, whereas Tegner scores showed no significant difference.Conclusion: Compared with MF alone, PRP + MF produced clinically meaningful improvement in functional outcomes and pain control. The results of the present study may provide preliminary evidence for selecting treatments for knee cartilage lesions. However, higher-quality clinical studies with more quantitative outcomes are needed to confirm these results and determine the long-term effectiveness and safety of PRP augmentation following MF.

DOI 10.1097/js9.0000000000004610

PMID 41427522

原文・出典を見る →